𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is There a Role for α-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

✍ Scribed by Dr André J. Scheen

Book ID
119927909
Publisher
Springer International Publishing AG
Year
2003
Tongue
English
Weight
253 KB
Volume
63
Category
Article
ISSN
0012-6667

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of Type 2 Diabetes || Decreas
Prevention of Type 2 Diabetes || Decreasing Postprandial Plasma Glucose Using an α-Glucosidase Inhibitor in Subjects with IGT for the Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Trial
✍ LeRoith, Derek 📂 Article 📅 2012 🏛 Springer New York 🌐 English ⚖ 597 KB

There Is A World-wide Epidemic On Obesity. This Epidemic Is Driving The Immense Proportions Of Type 2 Diabetes Across The Globe. While There Are Numerous Therapies For Treating Type 2 Diabetes, The Most Effective Therapy Is Prevention. Prevention Of Type 2 Diabetes Can Be Achieved Properly By Simult

Long-term effectiveness of a new α-gluco
Long-term effectiveness of a new α-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated Type 2 diabetes mellitus
✍ Mitrakou, A.; Tountas, N.; Raptis, A.E.; Bauer, R.J.; Schulz, H.; Raptis, S.A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

In a double-blind, randomized study, miglitol (BAY m 1099), an ␣-glucosidase inhibitor, 100 mg tds or placebo was given orally with meals for a period of 24 weeks in 117 patients with Type 2 (non-insulin-dependent) diabetes mellitus (DM) treated with insulin. Fasting and 1 h postprandial plasma gluc